Levocarnitine Tablet Composition And An Eco Friendly Aqueous System

Levocarnitine Tablet Composition And An Eco Friendly Aqueous System Based Manufacturing Process Thereof

Abstract: LEVOCARNITINE TABLET COMPOSITION AND AN ECO-FRIENDLY AQUEOUS SYSTEM BASED MANUFACTURING PROCESS THEREOF Levocarnitine tablets composition and eco-friendly aqueous system based manufacturing process is disclosed. Method of a preparation of stable, moisture protective L-Carnitine base tablet dosage form having protection from environmental moisture during storage in a controlled humidity conditions.

Patent Information

Application #

Filing Date

02 September 2022

Publication Number

10/2024

Publication Type

INA

Invention Field

BIOTECHNOLOGY

Status

Email

Parent Application

Applicants

Modi-Mundipharma Pvt. Ltd.

1400, Modi Tower, 98 Nehru Place, New Delhi-110019, India

Inventors

1. Rajesh Agrawal

Modi- Mundipharma Research & Development Centre, Modipuram, Meerut, UP, India

2. Awdhesh K. Omary

Modi- Mundipharma Research & Development Centre, Modipuram, Meerut, UP, India

3. Vishal Gupta

Modi- Mundipharma Research & Development Centre, Modipuram, Meerut, UP, India

4. Rakesh Khattar

Modi-Mundipharma (P) Ltd., 1400, Modi Tower, 98 Nehru Place, Delhi, India

5. Mukesh Sinha

Modi-Mundipharma (P) Ltd., 1400, Modi Tower, 98 Nehru Place, Delhi, India

6. Mithu Sen

Modi- Mundipharma Research & Development Centre, Modipuram, Meerut, UP, India

Specification

DESC:Attached ,CLAIMS:Attached

Documents

Application Documents

#	Name	Date
1	202211050285-STATEMENT OF UNDERTAKING (FORM 3) [02-09-2022(online)].pdf	2022-09-02
2	202211050285-PROVISIONAL SPECIFICATION [02-09-2022(online)].pdf	2022-09-02
3	202211050285-FORM 1 [02-09-2022(online)].pdf	2022-09-02
4	202211050285-CORRESPONDENCE-OTHERS [04-09-2023(online)].pdf	2023-09-04
5	202211050285-COMPLETE SPECIFICATION [04-09-2023(online)].pdf	2023-09-04
6	202211050285-Proof of Right [12-10-2023(online)].pdf	2023-10-12
7	202211050285-FORM-26 [12-10-2023(online)].pdf	2023-10-12
8	202211050285-Others-011123.pdf	2023-11-20
9	202211050285-GPA-011123.pdf	2023-11-20
10	202211050285-Correspondence-011123.pdf	2023-11-20